- Home
- PROV vs ONCY Comparison
PROV vs ONCY Comparison
Compare PROV & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROV
- ONCY
- Stock Information
- Founded
- PROV 1956
- ONCY 1998
- Country
- PROV United States
- ONCY Canada
- Employees
- PROV N/A
- ONCY N/A
- Industry
- PROV Savings Institutions
- ONCY Pharmaceuticals and Biotechnology
- Sector
- PROV Finance
- ONCY Health Care
- Exchange
- PROV Nasdaq
- ONCY Nasdaq
- Market Cap
- PROV 103.5M
- ONCY 89.7M
- IPO Year
- PROV 1996
- ONCY 1999
- Fundamental
- Price
- PROV $15.69
- ONCY $1.17
- Analyst Decision
- PROV Hold
- ONCY Strong Buy
- Analyst Count
- PROV 1
- ONCY 5
- Target Price
- PROV $16.50
- ONCY $5.00
- AVG Volume (30 Days)
- PROV 7.9K
- ONCY 934.1K
- Earning Date
- PROV 10-28-2025
- ONCY 11-07-2025
- Dividend Yield
- PROV 3.55%
- ONCY N/A
- EPS Growth
- PROV N/A
- ONCY N/A
- EPS
- PROV 0.90
- ONCY N/A
- Revenue
- PROV $39,823,000.00
- ONCY N/A
- Revenue This Year
- PROV $7.74
- ONCY N/A
- Revenue Next Year
- PROV $4.06
- ONCY N/A
- P/E Ratio
- PROV $17.55
- ONCY N/A
- Revenue Growth
- PROV 0.07
- ONCY N/A
- 52 Week Low
- PROV $12.98
- ONCY $0.33
- 52 Week High
- PROV $16.70
- ONCY $1.51
- Technical
- Relative Strength Index (RSI)
- PROV 48.99
- ONCY 45.03
- Support Level
- PROV $15.60
- ONCY $1.16
- Resistance Level
- PROV $15.98
- ONCY $1.32
- Average True Range (ATR)
- PROV 0.19
- ONCY 0.07
- MACD
- PROV -0.02
- ONCY -0.00
- Stochastic Oscillator
- PROV 40.92
- ONCY 33.33
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.